1-8 of 8
Fiona Errington
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 20: Oncolytic virotherapy enhances Smac mimetic treatment of acute myeloid leukemia

Joanne L. Hopper, Louise ME Müller, Victoria A. Jennings, Gina B. Scott, Stewart McConnell, Richard Kelly, Fiona Errington-Mais
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24_Supplement): 20.
https://doi.org/10.1158/1557-3265.HEMMAL17-20
Published: 14 December 2017
View article titled, Abstract 20: Oncolytic virotherapy enhances Smac mimetic treatment of acute myeloid leukemia
Journal Articles

Abstract 18: Evaluating the contribution of anti-myeloma immunity for the efficacy of oncolytic reovirus therapy

Louise M. E. Müller, Christopher Parrish, Gemma Migneco, Gina B. Scott, Matthew Holmes, Alan A. Melcher, Michelle A. Lawson, Gordon Cook, Fiona Errington-Mais
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24_Supplement): 18.
https://doi.org/10.1158/1557-3265.HEMMAL17-18
Published: 14 December 2017
View article titled, Abstract 18: Evaluating the contribution of anti-myeloma immunity for the efficacy of oncolytic reovirus therapy
Journal Articles

Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization

Elizabeth J. Ilett, Montserrat Bárcena, Fiona Errington-Mais, Stephen Griffin, Kevin J. Harrington, Hardev S. Pandha, Matthew Coffey, Peter J. Selby, Ronald W.A.L. Limpens, Mieke Mommaas, Rob C. Hoeben, Richard G. Vile, Alan A. Melcher
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (9): 2767–2776.
https://doi.org/10.1158/1078-0432.CCR-10-3266
Published: 01 May 2011
View article titled, Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization
Open the PDF for Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization in another window
Journal Articles

Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma

Hardev S. Pandha, Lucy Heinemann, Guy R. Simpson, Alan Melcher, Robin Prestwich, Fiona Errington, Matt Coffey, Kevin J. Harrington, Richard Morgan
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6158–6166.
https://doi.org/10.1158/1078-0432.CCR-09-0796
Published: 30 September 2009
View article titled, Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma
Open the PDF for Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma in another window
Journal Articles

Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication

Robin J. Prestwich, Elizabeth J. Ilett, Fiona Errington, Rosa M. Diaz, Lynette P. Steele, Tim Kottke, Jill Thompson, Feorillo Galivo, Kevin J. Harrington, Hardev S. Pandha, Peter J. Selby, Richard G. Vile, Alan A. Melcher
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (13): 4374–4381.
https://doi.org/10.1158/1078-0432.CCR-09-0334
Published: 01 July 2009
View article titled, Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication
Open the PDF for Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication in another window
Journal Articles

Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity

Robin J. Prestwich, Fiona Errington, Elizabeth J. Ilett, Ruth S.M. Morgan, Karen J. Scott, Timothy Kottke, Jill Thompson, Ewan E. Morrison, Kevin J. Harrington, Hardev S. Pandha, Peter J. Selby, Richard G. Vile, Alan A. Melcher
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (22): 7358–7366.
https://doi.org/10.1158/1078-0432.CCR-08-0831
Published: 14 November 2008
View article titled, Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
Open the PDF for Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity in another window
Journal Articles

Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy

Katie Twigger, Laura Vidal, Christine L. White, Johann S. De Bono, Shreerang Bhide, Matt Coffey, Brad Thompson, Richard G. Vile, Lucy Heinemann, Hardev S. Pandha, Fiona Errington, Alan A. Melcher, Kevin J. Harrington
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 912–923.
https://doi.org/10.1158/1078-0432.CCR-07-1400
Published: 01 February 2008
View article titled, Enhanced <em>In vitro</em> and <em>In vivo</em> Cytotoxicity of Combined Reovirus and Radiotherapy
Open the PDF for Enhanced <em>In vitro</em> and <em>In vivo</em> Cytotoxicity of Combined Reovirus and Radiotherapy in another window
Includes: Supplementary data
Journal Articles

Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.

Fiona Errington, Andrew Bateman, Tim Kottke, Jill Thompson, Kevin Harrington, Alison Merrick, Paul Hatfield, Peter Selby, Richard Vile, Alan Melcher
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (4): 1333–1341.
https://doi.org/10.1158/1078-0432.CCR-05-1113
Published: 17 February 2006
View article titled, Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.
Open the PDF for Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy. in another window